Pulmonary Embolism Centers of Excellence: Current Protocols and Innovative Treatment Approaches

Acute pulmonary embolism (PE) is a life-threatening pathology that potentially requires a wide range of diagnostic, therapeutic, and surgical interventions. Due to the complexity of differential diagnosis and clinical decision-making, as well as the extensive development of modern therapeutic and diagnostic methods for PE, a network of specialized expert-level PE centers has been established internationally. Such facilities allow concentrating qualified medical personnel and high-tech equipment to improve the quality of care for PE patients at intermediate-high and high-risk and to establish a scientific and educational base for future research and the updating of clinical guidelines. The implementation of PE centers can reduce in-hospital mortality and the duration of hospital and intensive care unit stay.

1. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Experimental and Clinical Cardiology. 2013;18(2):129–38. PMID: 23940438

2. Nikulina N.N., Terekhovskaya Yu.V. Epidemiology of pulmonary embolism in today’s context: analysis of incidence, mortality and problems of their study. Russian Journal of Cardiology. 2019;24(6):103–8. DOI: 10.15829/15604071-2019-6-103-108

3. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J, Harjola V-P et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2019;41(4):543–603. DOI: 10.1093/eurheartj/ehz405

4. Panchenko E.P., Balahonova T.V., Danilov N.M., Komarov A.L., Kropachyova E.S., Saidova M.A. et al. Diagnosis and management of pulmonary embolism Eurasian Association of Cardiology (EAC) clinical practice guidelines (2021). Eurasian Heart Journal. 2021;1(34):44– 77. DOI: 10.38109/2225-1685-2021-1-44-77

5. Bokeriya L.A., Zatevahin I.I., Kirienko A.I., Andriyashkin A.V., Andriyashkin V.V., Arutyunov G.P. et al. Russian clinical guidelines for the diagnosis, treatment and prevention of venous thromboembolic complications (VTEC). Flebology. 2015;9(4-2):1-52.

6. Ross CB, Sterling KM, Carroll B, Rosovsky RP, Rivera-Lebron B, Merli G. The Pulmonary Embolism Response Team and Hospital Relationship. P. 1-30. DOI: 10.1007/978-3-030-70904-4_48-1. In: PERT Consortium Handbook of Pulmonary Embolism. Grodzin CJ, Merli GJ, Ross CB, Rosovsky R, editors - Cham: Springer International Publishing; - 2024. ISBN: 978-3-030-70904-4

7. Roncon L, Casazza F, Zuin M, Zonzin P, Galli M, Enea I. Percutaneous treatment of pulmonary embolism: diffusion and use of the technique in Italian interventional cardiology centers. Results of the PETER survey. Giornale Italiano di Cardiologia. 2016;17(4):268– 72. DOI: 10.1714/2214.23900

8. Schultz J, Andersen A, Kabrhel C, Nielsen-Kudsk JE. Catheterbased therapies in acute pulmonary embolism. EuroIntervention. 2018;13(14):1721–7. DOI: 10.4244/EIJ-D-17-00437

9. Sista AK, Horowitz JM, Tapson VF, Rosenberg M, Elder MD, Schiro BJ et al. Indigo Aspiration System for Treatment of Pulmonary Embolism. JACC: Cardiovascular Interventions. 2021;14(3):319–29. DOI: 10.1016/j.jcin.2020.09.053

10. Garza JE, Shah P, Patel N, Wang D. Pulmonary Embolism With Syncope Treated With Inari FlowTriever®. Cureus. 2024;16(7):e64031. DOI: 10.7759/cureus.64031

11. Wang L, Yu C, Hu K, Guo Y, Li Y, Yu S et al. Research progress in interventional therapy for acute intermediate-high-risk and high-risk pulmonary embolism. Journal of Thoracic Disease. 2024;16(11):7958– 77. DOI: 10.21037/jtd-24-1049

12. Silver MJ, Gibson CM, Giri J, Khandhar S, Jaber W, Toma C et al. Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study. Circulation: Cardiovascular Interventions. 2023;16(10):e013406. DOI: 10.1161/CIRCINTERVENTIONS.123.013406

13. Gonsalves CF, Gibson CM, Stortecky S, Alvarez RA, Beam DM, Horowitz JM et al. Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study. American Heart Journal. 2023;266:128–37. DOI: 10.1016/j.ahj.2023.09.002

14. Pasha A, Ashraf M. Abstract 12155: Trends in the Clinical Outcomes and Resource Utilization of Catheter-Based Thrombolytic Therapy vs. Systemic Thrombolytic Therapy in Patients With Acute Pulmonary Embolism. Circulation. 2023;148(Suppl 1):12155. DOI: 10.1161/circ.148.suppl_1.12155

15. Monteleone P, Ahern R, Banerjee S, Desai KR, Kadian-Dodov D, Webber E et al. Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE). Journal of the Society for Cardiovascular Angiography & Interventions. 2024;3(1):101192. DOI: 10.1016/j.jscai.2023.101192

16. Zhang RS, Maqsood MH, Sharp ASP, Postelnicu R, Sethi SS, Greco A et al. Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC: Cardiovascular Interventions. 2023;16(21):2644–51. DOI: 10.1016/j.jcin.2023.07.042

17. Tefera L, Ziada KM, Cameron SJ. Pulmonary Embolism Unplugged: Catheter-Directed Therapies for Intermediate-Risk Pulmonary Embolism. JACC: Cardiovascular Interventions. 2023;16(21):2652–4. DOI: 10.1016/j.jcin.2023.08.029

18. Planer D, Yanko S, Matok I, Paltiel O, Zmiro R, Rotshild V et al. Cathe ter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. Canadian Medical Association Journal. 2023;195(24):E833–43. DOI: 10.1503/cmaj.220960

19. Klok FA, Piazza G, Sharp ASP, Ní Ainle F, Jaff MR, Chauhan N et al. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. American Heart Journal. 2022;251:43–53. DOI: 10.1016/j.ahj.2022.05.011

20. Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C et al. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clinical and Applied Thrombosis/Hemostasis. 2019;25:1076029619853037. DOI: 10.1177/1076029619853037

21. Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): Creation of a Multidisciplinary Program to Improve Care of Patients With Massive and Submassive Pulmonary Embolism. Hospital Practice. 2014;42(1):31–7. DOI: 10.3810/hp.2014.02.1089

22. Hobohm L, Farmakis IT, Keller K, Scibior B, Mavromanoli AC, Sagoschen I et al. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis. Clinical Research in Cardiology. 2023;112(10):1351–61. DOI: 10.1007/s00392-022-02077-0

23. DeVita MA, Bellomo R, Hillman K, Kellum J, Rotondi A, Teres D et al. Findings of the First Consensus Conference on Medical Emergency Teams. Critical Care Medicine. 2006;34(9):2463–78. DOI: 10.1097/01.CCM.0000235743.38172.6E

24. Meyer G, Vieillard-Baron A, Planquette B. Recent advances in the management of pulmonary embolism: focus on the critically ill patients. Annals of Intensive Care. 2016;6(1):19. DOI: 10.1186/s13613-016-0122-z

25. Rosenfield K, Rosovsky RP. Multidisciplinary Care for Pulmonary Embolism. 2017. Av. at: https://advances.massgeneral.org/cardiovascular/article.aspx?id=1007.

26. Mahar JH, Haddadin I, Sadana D, Gadre A, Evans N, Hornacek D et al. A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic. Journal of Thrombosis and Thrombolysis. 2018;46(2):186–92. DOI: 10.1007/s11239-018-1686-2

27. Chaudhury P, Gadre SK, Schneider E, Renapurkar RD, Gomes M, Haddadin I et al. Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes. The American Journal of Cardiology. 2019;124(9):1465–9. DOI: 10.1016/j.amjcard.2019.07.043

28. Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. Journal of Thrombosis and Thrombolysis. 2019;47(1):31–40. DOI: 10.1007/s11239-018-1737-8

29. Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K. A Multidisciplinary Pulmonary Embolism Response Team. Chest. 2013;144(5):1738–9. DOI: 10.1378/chest.13-1562

30. DeBerry J, Rali P, McDaniel M, Kabrhel C, Rosovsky R, Melamed R et al. Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis. Frontiers in Medicine. 2023;10:1080342. DOI: 10.3389/fmed.2023.1080342

31. Lookstein RA, Bowers TR. Update on the PERCTM Initiative and the PERT Database: 1 Year Later. Endovascular Today Supplement. 2023;22(7):8–11. Av. at: https://assets.bmctoday.net/evtoday/pdfs/et0723_PERT_Supp_sec%202.pdf

32. Rosovsky R, Zhao K, Sista A, Rivera‐Lebron B, Kabrhel C. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Research and Practice in Thrombosis and Haemostasis. 2019;3(3):315–30. DOI: 10.1002/rth2.12216

33. PERT Consortium. PE Centers of Excellence. Av. at: https://pertconsortium.org/centers-of-excellence/.

34. Vasilieva E.Yu., Plavunov N.F., Kalinskaya A.I., Savvinova P.P., Sapina A.I., Vvedenskiy G.A. et al. Organization of “infarct network” in Moscow and the results of its work over the five-year period. Russian Journal of Endovascular Surgery. 2018;5(2):288–94. DOI: 10.24183/2409-4080-2018-5-2-288-294

35. Shpektor A.V., Vasilieva E.Yu. ST-elevation myocardial infarction: from “acute myocardial infarction network” to shock-centers. Creative Cardiology. 2021;15(4):435–9. DOI: 10.24022/1997-3187-2021-15-4-435-439

36. Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC et al. Standardized Team-Based Care for Cardiogenic Shock. Journal of the American College of Cardiology. 2019;73(13):1659–69. DOI: 10.1016/j.jacc.2018.12.084

37. Alviar CL, Maqsood MH, Tehrani BN, Sinha S, Van Diepen S, Katz JN et al. Abstract 15975: Cardiogenic Shock Teams Are Associated With Lower Mortality, Bleeding and Vascular Complications: A Systematic Review and Meta-Analysis. Circulation. 2023;148(Suppl 1):15975. DOI: 10.1161/circ.148.suppl_1.15975

38. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K et al. Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circulation: Heart Failure. 2024;17(11):e011709. DOI: 10.1161/CIRCHEARTFAILURE.124.011709

39. Elrod JK, Fortenberry JL. The hub-and-spoke organization design: an avenue for serving patients well. BMC Health Services Research. 2017;17(S1):457. DOI: 10.1186/s12913-017-2341-x

40. Calé R, Pereira H, Ferreira F, Loureiro MJ. Blueprint for developing an effective pulmonary embolism response network. Revista Portuguesa de Cardiologia. 2023;42(6):491–501. DOI: 10.1016/j.repc.2022.06.017